Position in BLLN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,402,945
+$1,215,362 QoQ
Shares Held
43,108
+61.3% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TD Asset Management Inc holds $1,039,748,336 across 22 Diagnostics & Research names. BLLN ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
479,855 | $235,863,127 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
153,173 | $193,181,787 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
236,531 | $132,904,402 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,023,428 | $116,650,323 | |
| 5 | DHR |
Danaher Corp /De/
|
517,368 | $98,092,972 | |
| 6 | WAT |
Waters Corp /De/
|
266,536 | $79,374,420 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
133,053 | $63,890,720 | |
| 8 | NTRA |
Natera, Inc.
|
194,092 | $38,816,458 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,402,945 | 43,108 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,187,583 | 26,730 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||